Daily Debunk

Claim: People with blood type O are more protected against COVID-19.

Verdict: Lacks Context

Read the full story at: Health Feedback​

Social Media Disinfo

Fresh false claims about COVID-19 vaccine and 5G technology spread online in the Philippines.

Read the full story at: Agence France-Presse​

Factual Reads on Coronavirus

Swiss giant Novartis halts COVID-19 hydroxychloroquine study
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
-- Medical Express, June 20